The news comes nearly three months after the FDA approved Opill, the first over-the-counter contraceptive pill for women.
In addition to Opill, the administration is also looking at expanding coverage of smoking cessation products, folic acid for pregnancy, as well as certain breastfeeding products, The Hill reported.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
